Literature DB >> 18324926

Synthesis of water soluble bis-triazenoquinazolines: an unusual predicted mode of binding to the epidermal growth factor receptor tyrosine kinase.

Anne-Laure Larroque1, Brad Peori, Christopher Williams, You Qiang Fang, Qiyu Qiu, Zakaria Rachid, Bertrand J Jean-Claude.   

Abstract

A novel type of 3,3-disubstituted bis-triazenes containing an ethylaminoethyl linker flanked by two identical anilinoquinazoline ring was synthesized. These model molecules contained an N-ethylaminomorpholine moiety designed to enhance water solubility. Despite their significant bulkiness, they blocked epidermal growth factor receptor (EGFR) tyrosine kinase in a dose-dependent manner with IC(50) values in low micromolar range. Molecular modeling to predict the interactions of the molecule with the ATP binding site of EGFR suggests that the N-ethylaminomorpholine side chain plays a binding role.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18324926     DOI: 10.1111/j.1747-0285.2008.00638.x

Source DB:  PubMed          Journal:  Chem Biol Drug Des        ISSN: 1747-0277            Impact factor:   2.817


  4 in total

1.  Biological effects of novel "combi-targeting" molecule and its effect on DNA repair pathway in hormone-refractory prostate cancer.

Authors:  Youqiang Fang; Jieying Wu; Tengcheng Li; Yun Luo; Qiyu Qiu; Xinxin Quan; Li Gao; Wei Liu
Journal:  Am J Cancer Res       Date:  2015-07-15       Impact factor: 6.166

2.  Acid-Catalyzed Synthesis of Isatoic Anhydride-8-Secondary Amides Enables IASA Transformations for Medicinal Chemistry.

Authors:  Sudershan R Gondi; Althaf Shaik; Kenneth D Westover
Journal:  J Org Chem       Date:  2021-12-28       Impact factor: 4.198

3.  Target modulation by a kinase inhibitor engineered to induce a tandem blockade of the epidermal growth factor receptor (EGFR) and c-Src: the concept of type III combi-targeting.

Authors:  Suman Rao; Anne-Laure Larroque-Lombard; Lisa Peyrard; Cédric Thauvin; Zakaria Rachid; Christopher Williams; Bertrand J Jean-Claude
Journal:  PLoS One       Date:  2015-02-06       Impact factor: 3.240

4.  Synthesis, Anticancer Screening of Some Novel Trimethoxy Quinazolines and VEGFR2, EGFR Tyrosine Kinase Inhibitors Assay; Molecular Docking Studies.

Authors:  Abdulmalik S Altamimi; Adel S El-Azab; Sami G Abdelhamid; Mubarak A Alamri; Ashraf H Bayoumi; Safar M Alqahtani; Alhumaidi B Alabbas; Ali I Altharawi; Manal A Alossaimi; Menshawy A Mohamed
Journal:  Molecules       Date:  2021-05-18       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.